Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis A.

B Flehmig

    Bailliere'S Clinical Gastroenterology
    |September 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    Hepatitis A virus (HAV) is a heat-stable picornavirus with unique replication properties. New vaccines show good immunogenicity and a cell-cultured vaccine will soon be available.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients.

    European journal of medical research·2011
    Same author

    Genetic relatedness of Cuban HAV wild-type isolates.

    Journal of medical virology·2001
    Same author

    Transmission of hepatitis A virus infection despite vaccination.

    The New England journal of medicine·2000
    Same author

    Hepatitis C virus, rheumatoid factors, and disease progression.

    Lancet (London, England)·1998
    Same author

    Influence of the 5' noncoding region of hepatitis A virus strain GBM on its growth in different cell lines.

    The Journal of general virology·1997
    Same author

    Early appearance of neutralizing antibodies after vaccination with an inactivated hepatitis A vaccine.

    The Journal of infection·1997

    Area of Science:

    • Virology
    • Immunology

    Background:

    • Hepatitis A virus (HAV) is a small, non-enveloped picornavirus within the Enterovirus genus.
    • HAV exhibits unique biological characteristics, including slow replication and low yield in cell cultures.
    • The virus is known for its extreme stability to heat and pH variations.

    Purpose of the Study:

    • To describe the known properties of Hepatitis A virus.
    • To review the virus's biological features, replication, and in vivo elimination mechanisms.
    • To discuss the declining incidence of hepatitis A and the development of new vaccines.

    Main Methods:

    • Literature review of known Hepatitis A virus properties.
    • Analysis of viral structure, replication dynamics, and stability.
    • Evaluation of immune response and vaccine development studies.

    Related Experiment Videos

    Main Results:

    • HAV possesses distinct biological features compared to other picornaviruses, including slow replication and low yield.
    • The virus is highly stable to heat and pH; typically non-cytopathogenic, though variants may show in vitro effects.
    • In vivo virus elimination is attributed to HAV antigen-specific CD8+ lymphocytes.
    • Declining hepatitis A incidence in industrialized nations correlates with low antibody prevalence in younger populations.
    • Developed vaccines demonstrate good immunogenicity in human volunteer studies.

    Conclusions:

    • Hepatitis A virus has unique virological properties influencing its epidemiology and control.
    • Effective vaccines are available, with a new cell-cultured derived vaccine nearing market release.
    • Understanding HAV's characteristics is crucial for public health strategies and vaccine development.